コーパス検索結果 (left1)
通し番号をクリックするとPubMedの該当ページを表示します
1 hanged the person's worldview (OR, 1 .8; 95% CI, 1 .3-2.5); any of the following health problems: anxiety (OR, 3.1; 95% C
2 n was blocked when we added neutralizing antibodies against any of the following: 1) laminin (specifically laminin-1), 2)
3 spitalization within the previous 36 h, active dyspnea, and any of the following: 1) estimated glomerular filtration rate
4 s were defined according to currently consented criteria as any of the following: shortest preexcited RR interval during
5 rest was a documented limitation in life support defined as any of the following: 1) no cardiopulmonary resuscitation, 2)
7 absence of a major adverse cardiovascular event, defined as any of the following: death, cardiopulmonary resuscitation, m
9 -epidermal separation was significantly reduced by blocking any of the following: Fcgamma receptor binding (P = 0.048), e
10 ary outcome was a composite of treatment failure defined by any of the following occurring within 7 days of enrollment: i
11 y outcome was biochemical-clinical failure (BCF) defined by any of the following: PSA failure (nadir + 2), hormonal inter
12 participants) from 1991 up to Nov 30, 2007, which compared any of the following antidepressants at therapeutic dose rang
13 ies, the primary composite measure of HI-EOL care comprised any of the following: intravenous chemotherapy < 14 days from
14 A analysis failed to detect mutations in the genes encoding any of the following proteins: AChR subunits, rapsyn, ColQ, C
15 ntified, within each subsample, persons who had experienced any of the following triggers for violent acts between Januar
16 physician or outpatient claims at least 30 days apart--for any of the following diagnoses: ischemic and thrombotic event
17 rtality held in multivariate modeling after controlling for any of the following individually: PaO2/FIO2, oxygenation ind
18 Similarly, there were no significant differences for any of the following secondary outcome measures: mean total p
19 There were no significant differences among groups for any of the following variables: age, gender, previous myocard
20 ssociated with mortality after controlling individually for any of the following in multivariate models: PaO2/FIO2, oxyge
21 plication was defined as a surgical procedure performed for any of the following reasons: capsular contracture; rupture o
22 inics if they had no history of atrial fibrillation but had any of the following: CHA2DS2-VASc score of >/=2, sleep apnea
24 omavirus-positive patients (n = 943) were defined as having any of the following: a kidney biopsy with PV associated neph
26 come was defined as mortality or major morbidity, including any of the following: persistent periventricular echogenicity
27 tracorporeal treatment: Severe methanol poisoning including any of the following being attributed to methanol: coma, seiz
29 all-cause mortality and (2) time to the first occurrence of any of the following events: cardiac death, ischemic stroke,
30 The composite primary end point was the first occurrence of any of the following events: sudden cardiac death, sustained
31 The primary outcome was the time to the occurrence of any of the following: death, institutionalization, loss of th
32 The primary end point was the first occurrence of any of the following: new diagnosis of coronary artery diseas
33 Severe organ involvement was defined as the presence of any of the following: 1) in the kidney, scleroderma "renal cr
34 al to the stenosis (p = 0.03, p = 0.02) and the presence of any of the following: delayed achievement of patency (i.e., b
35 eurodevelopmental impairment was defined as the presence of any of the following: moderate to severe cerebral palsy, a co
36 the ventricle and impaired active relaxation as a result of any of the following: myocardial ischemia, hypertrophy, reduc
37 Six- and 12-month follow-up reports on use of any of the following tobacco products within the prior 6 mont
38 There was no difference between the groups on any of the following measures: episodes of incontinence decre
40 n increased risk for anovulation or cycle variability or to any of the following cycle endpoints: short luteal phase (< o
43 We first identified patients with CLD (n = 1565) with any of the following clinical characteristics: ascites, esoph
44 d when primary cultured rat hepatocytes were cotreated with any of the following agents that inhibit steps upstream of cy
46 eath, and congenital defects in pregnant women treated with any of the following: 1) a vitamin K antagonist (VKA) through
47 Survival to discharge and survival without any of the following adverse outcomes: grade III or IV intrav
WebLSDに未収録の専門用語（用法）は "新規対訳" から投稿できます。